
deepakbdk
108 posts





can be another doubler!!!! Fastest Moves above 450!!!! Stoploss 370 Target 700 / 1000 #lauruslabs #LaurusLab



#Lauruslab Approaching now long term resistance line










Classic case of operating leverage playing out Q2 -> Q3 : revenue increased by 24cr and EBITDA by 9cr --> 37.5% EBITDA on incremental revenues Q3 -> Q4 : revenue increased by 14cr and EBITDA by 7cr --> 50% EBITDA on incremental revenues Normalised PAT would have been 16-17cr ~ annual run-rate of 65-70cr on Q4 earnings. Company name : Navkar Corporation Disclosure : Please do your own research before taking any buy/sell action.


















Wave 5 has taken off well since the quoted tweet.






Solara Active Pharma Q1FY26 concall notes , my notes from the recent call concluded ( disc: invested and biased average price of 448 , no fresh reco no financial advice, initiated in march -25 )





